AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8742262 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory for contrast measured in separate blocks of trials
Number of subjects: 0
Study 8742262 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory for spatial frequency and contrast measured in an uncertainty paradigm
Number of subjects: 0
Study 2291418 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral zinc supplementation (45-90 mg of Zn2+, as zinc sulfate)
Number of subjects: 20
Study 7317899 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine 0 mg
Number of subjects: 10
Study 7317899 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg
Number of subjects: 10
Study 7317899 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 60 mg
Number of subjects: 10
Study 7317899 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 90 mg
Number of subjects: 10
Study 31504721 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sodium, high-cheese intervention (HNaC; 5500 mg/d sodium, 170 g/d cheese)
Number of subjects: 11
Study 31504721 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium, high-cheese intervention (LNaC; 1500 mg/d sodium, 170 g/d cheese)
Number of subjects: 11
Study 31504721 — intervention group
Group type: COMPARATOR
Intervention: High-sodium, no-dairy intervention (HNa; 5500 mg/d sodium)
Number of subjects: 11
Study 30845791 — intervention group
Group type: EXPERIMENTAL
Intervention: Solar salt aged for 3 years (SS)
Number of subjects: 0
Study 30845791 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified salt (PS)
Number of subjects: 0
Study 30845791 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamboo salt recrystalized 3 times (BS)
Number of subjects: 0
Study 30845791 — intervention group
Group type: COMPARATOR
Intervention: Non-starter (SSMJ)
Number of subjects: 0
Study 28716147 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week Gold Standard Programme (GSP)
Number of subjects: 110
Study 28716147 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual (control)
Number of subjects: 110
Study 25683074 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective transperitoneal needle aspiration of a bowel loop (STAB)
Number of subjects: 44
Study 25683074 — intervention group
Group type: COMPARATOR
Intervention: Conventional maneuvers (Control)
Number of subjects: 44
Study 25200141 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 24
Study 25200141 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 200 mg
Number of subjects: 24
Study 25200141 — intervention group
Group type: COMPARATOR
Intervention: Control (normal renal function or mild renal impairment)
Number of subjects: 24
Study 22270485 — intervention group
Group type: EXPERIMENTAL
Intervention: PRECOOL
Number of subjects: 13
Study 22270485 — intervention group
Group type: EXPERIMENTAL
Intervention: HEAT
Number of subjects: 13
Study 22270485 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 13
Study 19571529 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic WSS
Number of subjects: 379
Study 19571529 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic WSS
Number of subjects: 379
Study 17634109 — intervention group
Group type: EXPERIMENTAL
Intervention: Active counselling (educational intervention about the continuous dopaminergic hypothesis)
Number of subjects: 83
Study 17634109 — intervention group
Group type: COMPARATOR
Intervention: Standard management (control group)
Number of subjects: 83
Study 15220170 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 83
Study 15220170 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 83
Study 15220170 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 83
Study 15220170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 11274545 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-325 at 0.01 mmol/kg
Number of subjects: 26
Study 11274545 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-325 at 0.03 mmol/kg
Number of subjects: 26
Study 11274545 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-325 at 0.05 mmol/kg
Number of subjects: 26
Study 11274545 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-325 at 0.01 and 0.03 mmol/kg
Number of subjects: 26
Study 11274545 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-325 (all doses)
Number of subjects: 26
Study 11274545 — intervention group
Group type: COMPARATOR
Intervention: Conventional contrast agent-enhanced angiography
Number of subjects: 26
Study 9557374 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (25 mg bid)
Number of subjects: 21
Study 9557374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 7983579 — intervention group
Group type: EXPERIMENTAL
Intervention: Black source
Number of subjects: 0
Study 7983579 — intervention group
Group type: EXPERIMENTAL
Intervention: Low involvement message processing
Number of subjects: 0
Study 7983579 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes toward the source's ethnic group
Number of subjects: 0
Study 7983579 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction paradigm
Number of subjects: 0
Study 7983579 — intervention group
Group type: COMPARATOR
Intervention: White participants
Number of subjects: 0
Study 2463702 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable epidural opioid treatment (median dose: 90 mg morphine/24 hours, range 16‐600)
Number of subjects: 48
Study 2463702 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable epidural opioid treatment
Number of subjects: 48
Study 2463702 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural opioid treatment of neurogenic pain
Number of subjects: 48
Study 2463702 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural opioid treatment in low dosage group (less than 300 mg morphine/24 hours)
Number of subjects: 48
Study 2463702 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural opioid treatment in high dosage group (equal or greater than 300 mg morphine/24 hours)
Number of subjects: 48
Study 229506 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH-fragment 4-10 (30 mg SC)
Number of subjects: 0
Study 229506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31099281 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaoaiping (combined with routine chemotherapy)
Number of subjects: 93
Study 31099281 — intervention group
Group type: COMPARATOR
Intervention: Routine chemotherapy only (control group)
Number of subjects: 93
Study 28215654 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel + DCvac
Number of subjects: 43
Study 28215654 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 43
Study 25119055 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinless navigation
Number of subjects: 100
Study 25119055 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 100
Study 24084548 — intervention group
Group type: COMPARATOR
Intervention: Staples
Number of subjects: 63
Study 24084548 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular suture
Number of subjects: 63
Study 19825898 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol pretreatment
Number of subjects: 25
Study 19825898 — intervention group
Group type: COMPARATOR
Intervention: Placebo pretreatment
Number of subjects: 25
Study 19264686 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 61
Study 19264686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 16179207 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiautomated measurements of mesothelioma tumor thickness
Number of subjects: 22
Study 12781509 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery to treat end-stage disease
Number of subjects: 5900000
Study 12781509 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics to reduce the reservoir of infection
Number of subjects: 5900000
Study 12781509 — intervention group
Group type: COMPARATOR
Intervention: Health education and environmental improvement
Number of subjects: 5900000
Study 10365647 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine (plasma)
Number of subjects: 57
Study 10365647 — intervention group
Group type: EXPERIMENTAL
Intervention: Norclozapine (plasma)
Number of subjects: 57
Study 10365647 — intervention group
Group type: EXPERIMENTAL
Intervention: MPO activity
Number of subjects: 57
Study 8963479 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ramipril (ramiprilat)
Number of subjects: 0
Study 1904206 — intervention group
Group type: EXPERIMENTAL
Intervention: Oximeter and capnograph
Number of subjects: 402
Study 1904206 — intervention group
Group type: EXPERIMENTAL
Intervention: Only oximeter
Number of subjects: 402
Study 1904206 — intervention group
Group type: EXPERIMENTAL
Intervention: Only capnograph
Number of subjects: 402
Study 1904206 — intervention group
Group type: COMPARATOR
Intervention: Neither oximeter nor capnograph
Number of subjects: 402
Study 6261369 — intervention group
Group type: EXPERIMENTAL
Intervention: Veralipride (100 mg/day for 20 days)
Number of subjects: 43
Study 6261369 — intervention group
Group type: COMPARATOR
Intervention: Beta-alanine (during the same period)
Number of subjects: 43
Study 30179573 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-week dialectical behavior therapy (DBT) skills training group
Number of subjects: 42
Study 30497507 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/day of phytosterols and 10 g/day of inulin-enriched soymilk
Number of subjects: 26
Study 30497507 — intervention group
Group type: COMPARATOR
Intervention: Standard soymilk
Number of subjects: 26
Study 29297641 — intervention group
Group type: EXPERIMENTAL
Intervention: Perimenopausal women
Number of subjects: 111
Study 29297641 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 111
Study 29297641 — intervention group
Group type: EXPERIMENTAL
Intervention: Men in andropause
Number of subjects: 111
Study 29297641 — intervention group
Group type: COMPARATOR
Intervention: Control group (women)
Number of subjects: 111
Study 29297641 — intervention group
Group type: COMPARATOR
Intervention: Control group (men)
Number of subjects: 111
Study 24966398 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-directed intervention consisting of eight individual training sessions and a 3-month telephone support period.
Number of subjects: 44
Study 24966398 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-directed intervention
Number of subjects: 44
Study 22960644 — intervention group
Group type: EXPERIMENTAL
Intervention: Active monochromatic infrared energy (MIRE) therapy
Number of subjects: 73
Study 22960644 — intervention group
Group type: COMPARATOR
Intervention: Placebo MIRE therapy
Number of subjects: 73
Study 20077171 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 degrees rotation technique
Number of subjects: 120
Study 20077171 — intervention group
Group type: COMPARATOR
Intervention: Standard technique (index finger insertion)
Number of subjects: 120
Study 18821708 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine 500 mg 3 times daily
Number of subjects: 572
Study 18821708 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate 400 mg 3 times daily
Number of subjects: 572
Study 18821708 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of glucosamine and chondroitin sulfate
Number of subjects: 572
Study 18821708 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg daily
Number of subjects: 572
Study 18821708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 572
Study 15821826 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonal thrombocytemia
Number of subjects: 47
Study 15821826 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive thrombocytosis
Number of subjects: 47
Study 15821826 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 12388930 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostrinin® (100 μg of PRP complex) taken every other day for three weeks, followed by a 2-week hiatus, for a total of 16 months (or 28 months for 13 patients).
Number of subjects: 33
Study 12388930 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostrinin® (100 μg of PRP complex)
Number of subjects: 33
Study 10063412 — intervention group
Group type: EXPERIMENTAL
Intervention: Four layer bandaging
Number of subjects: 200
Study 10063412 — intervention group
Group type: EXPERIMENTAL
Intervention: Healed ulceration
Number of subjects: 200
Study 10063412 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 200
Study 7554753 — intervention group
Group type: EXPERIMENTAL
Intervention: Constipated patients with delayed transit time
Number of subjects: 76
Study 7554753 — intervention group
Group type: EXPERIMENTAL
Intervention: Constipated patients (all)
Number of subjects: 76
Study 7554753 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 76
Study 1971540 — intervention group
Group type: EXPERIMENTAL
Intervention: beta 1-blockade (atenolol, 50 mg, administered two times)
Number of subjects: 34
Study 1971540 — intervention group
Group type: EXPERIMENTAL
Intervention: beta 2-blockade (ICI 118,551, 50 mg, administered three times)
Number of subjects: 34
Study 1971540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 1971540 — intervention group
Group type: EXPERIMENTAL
Intervention: beta 2-blockade
Number of subjects: 34
Study 1971540 — intervention group
Group type: EXPERIMENTAL
Intervention: beta 1-blockade and beta 2-blockade
Number of subjects: 34
Study 7026038 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (1,000 units/ml) injected intraarterially at a dosage of 0.1 mg/kg prior to catheter removal
Number of subjects: 116
Study 7026038 — intervention group
Group type: COMPARATOR
Intervention: Placebo injected intraarterially at a dosage of 0.1 mg/kg prior to catheter removal
Number of subjects: 116
Study 7026038 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (1,000 units/ml)
Number of subjects: 116
Study 7026038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 30601417 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (30 mg 1 day before surgery and for 6 weeks after surgery)
Number of subjects: 80
Study 30601417 — intervention group
Group type: COMPARATOR
Intervention: Control group (no duloxetine)
Number of subjects: 80
Study 30601417 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 80
Study 28284879 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Breakfast (EB)
Number of subjects: 20
Study 25430996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 25430996 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg testosterone enanthate
Number of subjects: 71
Study 25430996 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.25 mg testosterone enanthate
Number of subjects: 71
Study 25430996 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg testosterone enanthate
Number of subjects: 71
Study 25430996 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg testosterone enanthate
Number of subjects: 71
Study 23594935 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle aspiration with rapid on-site evaluation
Number of subjects: 125
Study 23594935 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle aspiration without rapid on-site evaluation
Number of subjects: 125
Study 23594935 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods (forceps biopsy, brushing, bronchial washing)
Number of subjects: 125
Study 23594935 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle aspiration (with or without rapid on-site evaluation)
Number of subjects: 125
Study 21464051 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose statin
Number of subjects: 3341
Study 21464051 — intervention group
Group type: COMPARATOR
Intervention: Control (no statin/low-dose statin)
Number of subjects: 3341
Study 19432546 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc once daily
Number of subjects: 167
Study 19432546 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc twice daily
Number of subjects: 167
Study 19432546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 16750963 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular NSAID use (any NSAID) for 5 or more years
Number of subjects: 22071
Study 16750963 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular non-aspirin NSAID use
Number of subjects: 22071
Study 16750963 — intervention group
Group type: EXPERIMENTAL
Intervention: Any NSAID use
Number of subjects: 22071
Study 16750963 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of regular NSAID use
Number of subjects: 22071
Study 12745496 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX)
Number of subjects: 73
Study 12745496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 11056754 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonometered saline PCO2 measurement
Number of subjects: 15
Study 11056754 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric juice PCO2 measurement
Number of subjects: 15
Study 8989129 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsustained ventricular tachycardia (NSVT)
Number of subjects: 516
Study 8989129 — intervention group
Group type: EXPERIMENTAL
Intervention: Couplets
Number of subjects: 516
Study 8989129 — intervention group
Group type: EXPERIMENTAL
Intervention: Couplets and/or NSVT (ventricular repetitive beats)
Number of subjects: 516
Study 1536472 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (2 x 600 mg oral per day)
Number of subjects: 40
Study 1536472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 6387988 — intervention group
Group type: EXPERIMENTAL
Intervention: A/S
Number of subjects: 57
Study 6387988 — intervention group
Group type: COMPARATOR
Intervention: NI: ASA
Number of subjects: 57
Study 31562405 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 120
Study 31562405 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 120
Study 28341838 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Generated Path (FGP) technique
Number of subjects: 10
Study 28341838 — intervention group
Group type: EXPERIMENTAL
Intervention: Average-value FGP technique (AVR)
Number of subjects: 10
Study 28341838 — intervention group
Group type: COMPARATOR
Intervention: Conventional fabrication (CON)
Number of subjects: 10
Study 25833669 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamine-reduced diet (PRD)
Number of subjects: 80
Study 25833669 — intervention group
Group type: COMPARATOR
Intervention: Normal polyamine containing diet
Number of subjects: 80
Study 23638711 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding counselling (BFC)
Number of subjects: 3214
Study 23638711 — intervention group
Group type: COMPARATOR
Intervention: Usual/standard health message (UHM)
Number of subjects: 3214
Study 23638711 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal multiple micronutrients combined with BFC
Number of subjects: 3214
Study 23638711 — intervention group
Group type: COMPARATOR
Intervention: Prenatal 60 mg iron and folate combined with UHM
Number of subjects: 3214
Study 23638711 — intervention group
Group type: COMPARATOR
Intervention: BFC vs UHM
Number of subjects: 3214
Study 20702514 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniosacral therapy for 20 weeks
Number of subjects: 92
Study 20702514 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment with disconnected magnetotherapy equipment for 20 weeks
Number of subjects: 92
Study 19879226 — intervention group
Group type: EXPERIMENTAL
Intervention: RotaTeq vaccine
Number of subjects: 2686
Study 19879226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2686
Study 17117100 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical betacaine application
Number of subjects: 40
Study 17117100 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 40
Study 17117100 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical betacaine followed by skin cooling
Number of subjects: 40
Study 15265098 — intervention group
Group type: EXPERIMENTAL
Intervention: Helping during treatment
Number of subjects: 279
Study 15265098 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐step involvement
Number of subjects: 279
Study 11933878 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of steroids (oral or intramuscular dexamethasone, 0.6 mg/kg)
Number of subjects: 0
Study 11933878 — intervention group
Group type: COMPARATOR
Intervention: Steroid therapy
Number of subjects: 0
Study 11933878 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids in pharyngitis
Number of subjects: 0
Study 11933878 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose and short-term steroid therapy (less than a week)
Number of subjects: 0
Study 11933878 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine use of steroids for recurrent ENT infections
Number of subjects: 0
Study 9640129 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education program
Number of subjects: 60
Study 9640129 — intervention group
Group type: COMPARATOR
Intervention: Sulphasalazine therapy
Number of subjects: 60
Study 8115611 — intervention group
Group type: EXPERIMENTAL
Intervention: CT at 80 mAs (experimental group)
Number of subjects: 78
Study 8115611 — intervention group
Group type: COMPARATOR
Intervention: CT at 240 mAs (control group)
Number of subjects: 78
Study 2680431 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 174
Study 2680431 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K
Number of subjects: 174
Study 2680431 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (without ascites)
Number of subjects: 174
Study 2680431 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (with ascites)
Number of subjects: 174
Study 2680431 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K (with ascites)
Number of subjects: 174
Study 1093427 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 10 mg diazepam
Number of subjects: 1
Study 1093427 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection into the thigh of 10 mg diazepam
Number of subjects: 1